The Effective Statistician - in association with PSI

By Alexander Schacht and Benjamin Piske, biometricians, statisticians and leaders in the pharma industryScience Natural Sciences

The Effective Statistician - in association with PSI episodes

December 09, 2024Why is it important to measure exposure to digital health interventions and how to tackle the challenge
Interview with Jack Elkes
Key points:
Digital health interventions: Definition, scope, examples.
Engagement: Definition, importance, complexity.
Measurement challenges: Multidimensional data, variability, arbitrary definitions.
Mental health focus: Apps, virtual reality, stigma reduction, barriers to care.
Cluster analysis: Grouping users, multidimensional engagement measures, case studies.
Comparison to marketing: Engagement metrics, optimization, dynamic updates.
Risks and opportunities: Growing field, need for early research, potential harm.
Role of statisticians: Methodology, decentralized trials, PROs, future research.
Call to action: Explore the field, learn, engage with associations.
Digital health interventions are transforming healthcare, offering exciting opportunities and posing new challenges for statisticians and researchers alike. From defining engagement to tackling complex data with innovative methods, this field has much to explore.
I hope this episode inspires you to dive deeper into this growing area and consider how you can contribute to its evolution. If you found this discussion valuable, I encourage you to listen to the full episode and share it with your friends and colleagues who might benefit from these insights.
34 min
December 03, 2024Why Do Clinical Trials Impact the Climate Heavily and What We Can Do About It?
Interview with Annie Wright
Key points:
Environmental Impact
Carbon Footprint Drivers
Decentralized Trials
Study Design Simplification
Protocol Amendments
Waste Management
Greener Initiatives
Technology Adoption
Awareness and Collaboration
Call to Action
CO2 Calculators
Public and Private Collaboration
Clinical trials play a vital role in advancing healthcare, but their environmental impact cannot be ignored. By rethinking how we design and operate trials, we can reduce carbon emissions, streamline processes, and contribute to a greener future. Whether it’s embracing decentralized trials, simplifying study designs, or engaging in sustainability initiatives, we all have a part to play.
If this episode inspired you, share it with your friends and colleagues. Let’s spark conversations about making clinical research more sustainable and work together to create positive change. Don’t forget to listen, reflect, and take action—every step counts!
27 min
November 25, 2024Introduction to Dealing with Non-proportional Hazards
Interview with Kaspar Rufibach
Key points:
Non-Proportional Hazards: Understanding when and why the proportional hazards assumption fails.
Hazard Functions: Differences between survival functions and hazard functions; interpreting dynamics over time.
Data Visualization: Importance of visualizing hazard functions alongside Kaplan-Meier curves.
Clinical Context: Collaborating with clinicians to understand treatment effects and disease dynamics.
Effect Quantification: Exploring alternatives to hazard ratios when proportionality doesn’t hold.
Trial Design: Challenges in designing studies with non-proportional hazards and strategies to address them.
Simplification Risks: Avoiding oversimplifications like responder analysis or arbitrary sample size increases.
Stakeholder Communication: Explaining complex survival data effectively to non-statisticians.
Regulatory Considerations: Balancing valid hypothesis testing with meaningful effect quantification.
Actionable Insights: Practical steps for statisticians to improve survival analysis and trial design.
Dealing with non-proportional hazards is a complex but critical aspect of survival analysis, and understanding it can make a significant difference in your work. In this episode, Kaspar and I covered everything from hazard functions and survival curves to practical strategies for trial design and effect quantification. If you found these insights valuable, don’t keep them to yourself!
Share this episode with your friends and colleagues who work with survival analysis or clinical trials. And if you haven’t already, make sure to subscribe so you never miss an episode of The Effective Statistician. Let’s work together to elevate the impact of statistics in healthcare!
44 min
November 18, 2024How Real Leaders Help Their People Grow Professionally and As a Person
Interview with Aziza Yormizaeva and Klaus Breuer
Key points:
Leadership: Building trust, inspiring growth, and prioritizing collaboration.
Mentorship: Klaus guiding Aziza to discover her passion for statistics.
Professional Growth: Empowering team members to learn and succeed.
Authenticity: Honest communication and standing by data-driven insights.
Collaboration: Creating win-win situations for individuals and the organization.
Trust-Building: Establishing credibility through support and training.
Empowerment: Teaching others to leverage tools and make informed decisions.
Sustainable Value: Creating systems that deliver results even in your absence.
Continuous Learning: Both leaders and team members growing together.
Personal Growth: Developing not just careers, but individuals as a whole.
This episode highlights the transformative power of authentic leadership, trust, and mentorship in driving both personal and professional growth. Aziza and Klaus show us how fostering collaboration and empowering others can create lasting value for individuals and organizations alike. Their story is filled with practical lessons and inspiring insights that can help you on your own journey as a statistician, leader, or team member.
47 min
November 11, 2024Clinical Development of Gene Therapies
Interview with Oscar Segurado, MD PhD
Key points:
Gene Therapy Uniqueness: Differences from traditional drug development
Safety & Dosing: Single-dose approach, safety considerations
Statisticians' Role: Essential contributions in planning and analysis
Guest Background: Oscar’s expertise in academia, med tech, biopharma, Humira development
Clinical Development: Phases from trials to commercialization
Rare Disease Focus: Hemophilia A, spinal muscular atrophy
Challenges & Opportunities: Unique clinical and statistical challenges
Future of Medicine: Insights into advancements in gene therapy
Oscar’s expertise sheds light on the unique challenges and groundbreaking possibilities in this field, highlighting the critical role that statisticians and data scientists play in advancing these therapies.
If you found this episode insightful, I encourage you to listen in full and share it with colleagues, friends, or anyone interested in the future of healthcare. Let’s spread the word on how statistical expertise is driving the next frontier in medicine—tune in, learn, and pass it on!
30 min
November 04, 2024Statistical Topics in Gene Therapy
Interview with Avery McIntosh and Oleksandr Sverdlov
Key points:
Gene Therapy Potential
Role of Statisticians
Guest Experts Overview
Challenges
Statistical Innovation
Current Impact
Future Outlook
Audience Insight
Podcast Goals
In this episode, we dive deep into the science, the ethical hurdles, and the innovative statistical methods that make gene therapy possible. I encourage you to tune in and gain insights from our expert guests, Avery and Alex, as they share their experiences and perspectives on navigating this complex field.
If you find this episode valuable, please share it with colleagues, friends, and anyone interested in the future of medicine and data science. Let’s spread the knowledge and excitement around these life-changing advancements!
43 min
October 28, 2024Clinical Development Plans
Interview with Carrie Li
Key points:
Clinical Development Plan (CDP): strategy for compound progression
Early Decisions: impact on clinical phases, timeline, cost
Statistical Role: balancing science, speed, and cost
Target Product Profile (TPP): guides CDP objectives
Cross-functional Collaboration: clinical, commercial, regulatory teams
Big Pharma vs. Startups: differences in resources, risk, investor expectations
Adaptive Design: flexibility in clinical phases, risk management
Regulatory Engagement: early involvement of FDA, EMA for approvals
Competitor Landscape: use of competitive intelligence for CDP design
Cost & Timeline Estimation: sample size, Gantt chart for budgeting
Together, we explore how to balance scientific rigor with business goals, collaborate across teams, and navigate the regulatory landscape to bring new therapies to life. Carrie shares practical advice and insights that can help anyone involved in drug development make a real impact.
Don’t miss this conversation—listen to the full episode, and if you find it valuable, share it with friends and colleagues who are passionate about advancing healthcare.
36 min
October 21, 2024The Most Important Things You Need to Know About AI And ML
Interview with Pietro Mascheroni
Key points:
Large Language Models (LLMs): Role in transforming work processes, especially in AI and machine learning.
Practical Applications: Document retrieval, data exploration, code refinement.
Human Oversight: Importance of keeping human input in AI-assisted processes.
Communication: AI's potential to improve team communication and collaboration.
Validation Challenges: Ensuring accuracy and reliability of AI models.
Pharmaceutical Research: Use of LLMs in clinical trials, eligibility criteria, and patient data analysis.
AI Efficiency: How LLMs streamline workflows and reduce repetitive tasks.
Future of AI: Evolving capabilities of LLMs and the need to stay ahead in the field.
This episode reveals how large language models (LLMs) are transforming industries like pharmaceutical research and statistics. Pietro shares practical applications and emphasizes the need for human oversight, showcasing how AI is reshaping the way we work.
If you want to stay ahead in this rapidly evolving AI field, listen to this episode today! Be sure to share the episode link with colleagues and friends who can benefit from learning how AI can boost efficiency and collaboration. Tune in now!
46 min
October 14, 2024Can Statisticians Contribute to Moving Out of The Statistics Function?
Interview with Swarna Khare
Key points:
Expanding Careers: Statisticians moving beyond traditional statistics roles.
Transferable Skills: Data interpretation, strategic thinking, communication.
Career Transition: Swarna’s journey from statistician to strategic roles.
Broader Impact: Using statistical skills in non-technical positions.
Practical Advice: How statisticians can leverage their expertise.
Opportunities: New career paths and roles outside statistics.
Actionable Insights: Steps for statisticians to broaden their horizons.
In this episode, Swarna’s journey shows how statisticians can successfully move beyond the traditional boundaries of their roles and make a broader impact in various industries. If you're looking to take your skills to the next level and explore new career opportunities, this episode is full of valuable insights and practical advice.
42 min
October 07, 2024How Notion Can Help You With Productivity
Interview with Taina Pereenniemi
Key points:
Introduction to Notion
Taina’s Journey
Key Features of Notion
Collaboration & Integration
Productivity Benefits
Generative AI
Replacing Other Tools
Getting Started with Notion
Paid Features
Conference Workshop
Taina shares invaluable tips on getting started with Notion and highlights its potential to replace multiple tools while simplifying your personal and professional life.
Don’t miss out—tune in to the episode now and discover how you can start using Notion effectively. And if you found this episode helpful, be sure to share it with your colleagues and friends who could benefit from optimizing their productivity!
34 min

About The Effective Statistician - in association with PSI

From the publisher's feed

The podcast from statisticians for statisticians to have a bigger impact at work. This podcast is set up in association with PSI - Promoting Statistical Insight. This podcast helps you to grow your…